'' antibody diagnostic kit, method of detecting cd70 expression in a tissue sample, method for predicting, determining a treatment protocol or monitoring treatment, use of a cd70 binding agent, and combination of a diagnostic kit and a pharmaceutical kit
The application provides methods of diagnosis, prognosis, prophylaxis and treatment of ovarian, pancreatic and other cancers using antibodies that specifically bind to denatured CD70.